LSI awarded R01 to develop activity sensors to monitor immunotherapy efficacy

LSI has received a $1.8 million grant from the National Cancer Institute at the National Institutes of Health to develop activity sensors to monitor responses to cancer immunotherapy! This work will expand our sensor platform, which has already been used to detect thrombosis, liver fibrosis, cancer, and organ transplant rejection. Read more about this work here.

Posted in Uncategorized.